Pre-order Enquiry
Request Free Sample
Global Biosimilar of Remicade Market Size, Status and Forecast 2021-2027
SKU ID : QYR-19329693 | Publishing Date : 13-Oct-2021 | No. of pages : 116
Detailed TOC of Global Biosimilar of Remicade Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilar of Remicade Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Erythropoietin
1.2.5 Insulin
1.2.6 Vaccines
1.2.7 Other
1.3 Market by Application
1.3.1 Global Biosimilar of Remicade Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar of Remicade Market Perspective (2016-2027)
2.2 Biosimilar of Remicade Growth Trends by Regions
2.2.1 Biosimilar of Remicade Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biosimilar of Remicade Historic Market Share by Regions (2016-2021)
2.2.3 Biosimilar of Remicade Forecasted Market Size by Regions (2022-2027)
2.3 Biosimilar of Remicade Industry Dynamic
2.3.1 Biosimilar of Remicade Market Trends
2.3.2 Biosimilar of Remicade Market Drivers
2.3.3 Biosimilar of Remicade Market Challenges
2.3.4 Biosimilar of Remicade Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilar of Remicade Players by Revenue
3.1.1 Global Top Biosimilar of Remicade Players by Revenue (2016-2021)
3.1.2 Global Biosimilar of Remicade Revenue Market Share by Players (2016-2021)
3.2 Global Biosimilar of Remicade Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biosimilar of Remicade Revenue
3.4 Global Biosimilar of Remicade Market Concentration Ratio
3.4.1 Global Biosimilar of Remicade Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilar of Remicade Revenue in 2020
3.5 Biosimilar of Remicade Key Players Head office and Area Served
3.6 Key Players Biosimilar of Remicade Product Solution and Service
3.7 Date of Enter into Biosimilar of Remicade Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar of Remicade Breakdown Data by Type
4.1 Global Biosimilar of Remicade Historic Market Size by Type (2016-2021)
4.2 Global Biosimilar of Remicade Forecasted Market Size by Type (2022-2027)
5 Biosimilar of Remicade Breakdown Data by Application
5.1 Global Biosimilar of Remicade Historic Market Size by Application (2016-2021)
5.2 Global Biosimilar of Remicade Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biosimilar of Remicade Market Size (2016-2027)
6.2 North America Biosimilar of Remicade Market Size by Type
6.2.1 North America Biosimilar of Remicade Market Size by Type (2016-2021)
6.2.2 North America Biosimilar of Remicade Market Size by Type (2022-2027)
6.2.3 North America Biosimilar of Remicade Market Size by Type (2016-2027)
6.3 North America Biosimilar of Remicade Market Size by Application
6.3.1 North America Biosimilar of Remicade Market Size by Application (2016-2021)
6.3.2 North America Biosimilar of Remicade Market Size by Application (2022-2027)
6.3.3 North America Biosimilar of Remicade Market Size by Application (2016-2027)
6.4 North America Biosimilar of Remicade Market Size by Country
6.4.1 North America Biosimilar of Remicade Market Size by Country (2016-2021)
6.4.2 North America Biosimilar of Remicade Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biosimilar of Remicade Market Size (2016-2027)
7.2 Europe Biosimilar of Remicade Market Size by Type
7.2.1 Europe Biosimilar of Remicade Market Size by Type (2016-2021)
7.2.2 Europe Biosimilar of Remicade Market Size by Type (2022-2027)
7.2.3 Europe Biosimilar of Remicade Market Size by Type (2016-2027)
7.3 Europe Biosimilar of Remicade Market Size by Application
7.3.1 Europe Biosimilar of Remicade Market Size by Application (2016-2021)
7.3.2 Europe Biosimilar of Remicade Market Size by Application (2022-2027)
7.3.3 Europe Biosimilar of Remicade Market Size by Application (2016-2027)
7.4 Europe Biosimilar of Remicade Market Size by Country
7.4.1 Europe Biosimilar of Remicade Market Size by Country (2016-2021)
7.4.2 Europe Biosimilar of Remicade Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biosimilar of Remicade Market Size (2016-2027)
8.2 Asia-Pacific Biosimilar of Remicade Market Size by Type
8.2.1 Asia-Pacific Biosimilar of Remicade Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biosimilar of Remicade Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biosimilar of Remicade Market Size by Type (2016-2027)
8.3 Asia-Pacific Biosimilar of Remicade Market Size by Application
8.3.1 Asia-Pacific Biosimilar of Remicade Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biosimilar of Remicade Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biosimilar of Remicade Market Size by Application (2016-2027)
8.4 Asia-Pacific Biosimilar of Remicade Market Size by Region
8.4.1 Asia-Pacific Biosimilar of Remicade Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biosimilar of Remicade Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biosimilar of Remicade Market Size (2016-2027)
9.2 Latin America Biosimilar of Remicade Market Size by Type
9.2.1 Latin America Biosimilar of Remicade Market Size by Type (2016-2021)
9.2.2 Latin America Biosimilar of Remicade Market Size by Type (2022-2027)
9.2.3 Latin America Biosimilar of Remicade Market Size by Type (2016-2027)
9.3 Latin America Biosimilar of Remicade Market Size by Application
9.3.1 Latin America Biosimilar of Remicade Market Size by Application (2016-2021)
9.3.2 Latin America Biosimilar of Remicade Market Size by Application (2022-2027)
9.3.3 Latin America Biosimilar of Remicade Market Size by Application (2016-2027)
9.4 Latin America Biosimilar of Remicade Market Size by Country
9.4.1 Latin America Biosimilar of Remicade Market Size by Country (2016-2021)
9.4.2 Latin America Biosimilar of Remicade Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimilar of Remicade Market Size (2016-2027)
10.2 Middle East & Africa Biosimilar of Remicade Market Size by Type
10.2.1 Middle East & Africa Biosimilar of Remicade Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biosimilar of Remicade Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biosimilar of Remicade Market Size by Type (2016-2027)
10.3 Middle East & Africa Biosimilar of Remicade Market Size by Application
10.3.1 Middle East & Africa Biosimilar of Remicade Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biosimilar of Remicade Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biosimilar of Remicade Market Size by Application (2016-2027)
10.4 Middle East & Africa Biosimilar of Remicade Market Size by Country
10.4.1 Middle East & Africa Biosimilar of Remicade Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biosimilar of Remicade Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Biosimilar of Remicade Introduction
11.1.4 Roche Revenue in Biosimilar of Remicade Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Biosimilar of Remicade Introduction
11.2.4 Amgen Revenue in Biosimilar of Remicade Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Biosimilar of Remicade Introduction
11.3.4 AbbVie Revenue in Biosimilar of Remicade Business (2016-2021)
11.3.5 AbbVie Recent Development
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Details
11.4.2 Sanofi-Aventis Business Overview
11.4.3 Sanofi-Aventis Biosimilar of Remicade Introduction
11.4.4 Sanofi-Aventis Revenue in Biosimilar of Remicade Business (2016-2021)
11.4.5 Sanofi-Aventis Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Biosimilar of Remicade Introduction
11.5.4 Johnson & Johnson Revenue in Biosimilar of Remicade Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Biosimilar of Remicade Introduction
11.6.4 Pfizer Revenue in Biosimilar of Remicade Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Details
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Biosimilar of Remicade Introduction
11.7.4 Novo Nordisk Revenue in Biosimilar of Remicade Business (2016-2021)
11.7.5 Novo Nordisk Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Biosimilar of Remicade Introduction
11.8.4 Eli Lilly Revenue in Biosimilar of Remicade Business (2016-2021)
11.8.5 Eli Lilly Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Biosimilar of Remicade Introduction
11.9.4 Novartis Revenue in Biosimilar of Remicade Business (2016-2021)
11.9.5 Novartis Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Biosimilar of Remicade Introduction
11.10.4 Merck Revenue in Biosimilar of Remicade Business (2016-2021)
11.10.5 Merck Recent Development
11.11 3sbio
11.11.1 3sbio Company Details
11.11.2 3sbio Business Overview
11.11.3 3sbio Biosimilar of Remicade Introduction
11.11.4 3sbio Revenue in Biosimilar of Remicade Business (2016-2021)
11.11.5 3sbio Recent Development
11.12 Changchun High Tech
11.12.1 Changchun High Tech Company Details
11.12.2 Changchun High Tech Business Overview
11.12.3 Changchun High Tech Biosimilar of Remicade Introduction
11.12.4 Changchun High Tech Revenue in Biosimilar of Remicade Business (2016-2021)
11.12.5 Changchun High Tech Recent Development
11.13 CP Guojian
11.13.1 CP Guojian Company Details
11.13.2 CP Guojian Business Overview
11.13.3 CP Guojian Biosimilar of Remicade Introduction
11.13.4 CP Guojian Revenue in Biosimilar of Remicade Business (2016-2021)
11.13.5 CP Guojian Recent Development
11.14 Biotech
11.14.1 Biotech Company Details
11.14.2 Biotech Business Overview
11.14.3 Biotech Biosimilar of Remicade Introduction
11.14.4 Biotech Revenue in Biosimilar of Remicade Business (2016-2021)
11.14.5 Biotech Recent Development
11.15 Gelgen
11.15.1 Gelgen Company Details
11.15.2 Gelgen Business Overview
11.15.3 Gelgen Biosimilar of Remicade Introduction
11.15.4 Gelgen Revenue in Biosimilar of Remicade Business (2016-2021)
11.15.5 Gelgen Recent Development
11.16 Innovent
11.16.1 Innovent Company Details
11.16.2 Innovent Business Overview
11.16.3 Innovent Biosimilar of Remicade Introduction
11.16.4 Innovent Revenue in Biosimilar of Remicade Business (2016-2021)
11.16.5 Innovent Recent Development
11.17 Dong Bao
11.17.1 Dong Bao Company Details
11.17.2 Dong Bao Business Overview
11.17.3 Dong Bao Biosimilar of Remicade Introduction
11.17.4 Dong Bao Revenue in Biosimilar of Remicade Business (2016-2021)
11.17.5 Dong Bao Recent Development
11.18 Ganlee
11.18.1 Ganlee Company Details
11.18.2 Ganlee Business Overview
11.18.3 Ganlee Biosimilar of Remicade Introduction
11.18.4 Ganlee Revenue in Biosimilar of Remicade Business (2016-2021)
11.18.5 Ganlee Recent Development
11.18 United Laboratories
.1 United Laboratories Company Details
.2 United Laboratories Business Overview
.3 United Laboratories Biosimilar of Remicade Introduction
.4 United Laboratories Revenue in Biosimilar of Remicade Business (2016-2021)
.5 United Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Biosimilar of Remicade Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Biosimilar of Remicade Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Interferon
Table 4. Key Players of Erythropoietin
Table 5. Key Players of Insulin
Table 6. Key Players of Vaccines
Table 7. Key Players of Other
Table 8. Global Biosimilar of Remicade Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Biosimilar of Remicade Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Biosimilar of Remicade Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Biosimilar of Remicade Market Share by Regions (2016-2021)
Table 12. Global Biosimilar of Remicade Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Biosimilar of Remicade Market Share by Regions (2022-2027)
Table 14. Biosimilar of Remicade Market Trends
Table 15. Biosimilar of Remicade Market Drivers
Table 16. Biosimilar of Remicade Market Challenges
Table 17. Biosimilar of Remicade Market Restraints
Table 18. Global Biosimilar of Remicade Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Biosimilar of Remicade Market Share by Players (2016-2021)
Table 20. Global Top Biosimilar of Remicade Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar of Remicade as of 2020)
Table 21. Ranking of Global Top Biosimilar of Remicade Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Biosimilar of Remicade Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Biosimilar of Remicade Product Solution and Service
Table 25. Date of Enter into Biosimilar of Remicade Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Biosimilar of Remicade Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Biosimilar of Remicade Revenue Market Share by Type (2016-2021)
Table 29. Global Biosimilar of Remicade Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Biosimilar of Remicade Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Biosimilar of Remicade Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Biosimilar of Remicade Revenue Market Share by Application (2016-2021)
Table 33. Global Biosimilar of Remicade Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Biosimilar of Remicade Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Biosimilar of Remicade Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Biosimilar of Remicade Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Biosimilar of Remicade Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Biosimilar of Remicade Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Biosimilar of Remicade Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Biosimilar of Remicade Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Biosimilar of Remicade Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Biosimilar of Remicade Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Biosimilar of Remicade Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Biosimilar of Remicade Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Biosimilar of Remicade Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Biosimilar of Remicade Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Biosimilar of Remicade Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Biosimilar of Remicade Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Biosimilar of Remicade Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Biosimilar of Remicade Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Biosimilar of Remicade Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Biosimilar of Remicade Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Biosimilar of Remicade Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Biosimilar of Remicade Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Biosimilar of Remicade Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Biosimilar of Remicade Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Biosimilar of Remicade Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Biosimilar of Remicade Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Biosimilar of Remicade Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Biosimilar of Remicade Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Biosimilar of Remicade Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Biosimilar of Remicade Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Biosimilar of Remicade Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Biosimilar of Remicade Market Size by Country (2022-2027) & (US$ Million)
Table 65. Roche Company Details
Table 66. Roche Business Overview
Table 67. Roche Biosimilar of Remicade Product
Table 68. Roche Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 69. Roche Recent Development
Table 70. Amgen Company Details
Table 71. Amgen Business Overview
Table 72. Amgen Biosimilar of Remicade Product
Table 73. Amgen Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 74. Amgen Recent Development
Table 75. AbbVie Company Details
Table 76. AbbVie Business Overview
Table 77. AbbVie Biosimilar of Remicade Product
Table 78. AbbVie Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 79. AbbVie Recent Development
Table 80. Sanofi-Aventis Company Details
Table 81. Sanofi-Aventis Business Overview
Table 82. Sanofi-Aventis Biosimilar of Remicade Product
Table 83. Sanofi-Aventis Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 84. Sanofi-Aventis Recent Development
Table 85. Johnson & Johnson Company Details
Table 86. Johnson & Johnson Business Overview
Table 87. Johnson & Johnson Biosimilar of Remicade Product
Table 88. Johnson & Johnson Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 89. Johnson & Johnson Recent Development
Table 90. Pfizer Company Details
Table 91. Pfizer Business Overview
Table 92. Pfizer Biosimilar of Remicade Product
Table 93. Pfizer Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 94. Pfizer Recent Development
Table 95. Novo Nordisk Company Details
Table 96. Novo Nordisk Business Overview
Table 97. Novo Nordisk Biosimilar of Remicade Product
Table 98. Novo Nordisk Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 99. Novo Nordisk Recent Development
Table 100. Eli Lilly Company Details
Table 101. Eli Lilly Business Overview
Table 102. Eli Lilly Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 103. Eli Lilly Recent Development
Table 104. Novartis Company Details
Table 105. Novartis Business Overview
Table 106. Novartis Biosimilar of Remicade Product
Table 107. Novartis Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 108. Novartis Recent Development
Table 109. Merck Company Details
Table 110. Merck Business Overview
Table 111. Merck Biosimilar of Remicade Product
Table 112. Merck Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 113. Merck Recent Development
Table 114. 3sbio Company Details
Table 115. 3sbio Business Overview
Table 116. 3sbio Biosimilar of Remicade Product
Table 117. 3sbio Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 118. 3sbio Recent Development
Table 119. Changchun High Tech Company Details
Table 120. Changchun High Tech Business Overview
Table 121. Changchun High Tech Biosimilar of Remicade Product
Table 122. Changchun High Tech Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 123. Changchun High Tech Recent Development
Table 124. CP Guojian Company Details
Table 125. CP Guojian Business Overview
Table 126. CP Guojian Biosimilar of Remicade Product
Table 127. CP Guojian Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 128. CP Guojian Recent Development
Table 129. Biotech Company Details
Table 130. Biotech Business Overview
Table 131. Biotech Biosimilar of Remicade Product
Table 132. Biotech Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 133. Biotech Recent Development
Table 134. Gelgen Company Details
Table 135. Gelgen Business Overview
Table 136. Gelgen Biosimilar of Remicade Product
Table 137. Gelgen Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 138. Gelgen Recent Development
Table 139. Innovent Company Details
Table 140. Innovent Business Overview
Table 141. Innovent Biosimilar of Remicade Product
Table 142. Innovent Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 143. Innovent Recent Development
Table 144. Dong Bao Company Details
Table 145. Dong Bao Business Overview
Table 146. Dong Bao Biosimilar of Remicade Product
Table 147. Dong Bao Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 148. Dong Bao Recent Development
Table 149. Ganlee Company Details
Table 150. Ganlee Business Overview
Table 151. Ganlee Biosimilar of Remicade Product
Table 152. Ganlee Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 153. Ganlee Recent Development
Table 154. United Laboratories Company Details
Table 155. United Laboratories Business Overview
Table 156. United Laboratories Biosimilar of Remicade Product
Table 157. United Laboratories Revenue in Biosimilar of Remicade Business (2016-2021) & (US$ Million)
Table 158. United Laboratories Recent Development
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilar of Remicade Market Share by Type: 2020 VS 2027
Figure 2. Monoclonal Antibodies Features
Figure 3. Interferon Features
Figure 4. Erythropoietin Features
Figure 5. Insulin Features
Figure 6. Vaccines Features
Figure 7. Other Features
Figure 8. Global Biosimilar of Remicade Market Share by Application: 2020 VS 2027
Figure 9. Tumor Case Studies
Figure 10. Diabetes Case Studies
Figure 11. Cardiovascular Case Studies
Figure 12. Hemophilia Case Studies
Figure 13. Other Case Studies
Figure 14. Biosimilar of Remicade Report Years Considered
Figure 15. Global Biosimilar of Remicade Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Biosimilar of Remicade Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Biosimilar of Remicade Market Share by Regions: 2020 VS 2027
Figure 18. Global Biosimilar of Remicade Market Share by Regions (2022-2027)
Figure 19. Global Biosimilar of Remicade Market Share by Players in 2020
Figure 20. Global Top Biosimilar of Remicade Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar of Remicade as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Biosimilar of Remicade Revenue in 2020
Figure 22. Global Biosimilar of Remicade Revenue Market Share by Type (2016-2021)
Figure 23. Global Biosimilar of Remicade Revenue Market Share by Type (2022-2027)
Figure 24. North America Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Biosimilar of Remicade Market Share by Type (2016-2027)
Figure 26. North America Biosimilar of Remicade Market Share by Application (2016-2027)
Figure 27. North America Biosimilar of Remicade Market Share by Country (2016-2027)
Figure 28. United States Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Biosimilar of Remicade Market Share by Type (2016-2027)
Figure 32. Europe Biosimilar of Remicade Market Share by Application (2016-2027)
Figure 33. Europe Biosimilar of Remicade Market Share by Country (2016-2027)
Figure 34. Germany Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Biosimilar of Remicade Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Biosimilar of Remicade Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Biosimilar of Remicade Market Share by Region (2016-2027)
Figure 44. China Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Biosimilar of Remicade Market Share by Type (2016-2027)
Figure 52. Latin America Biosimilar of Remicade Market Share by Application (2016-2027)
Figure 53. Latin America Biosimilar of Remicade Market Share by Country (2016-2027)
Figure 54. Mexico Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Biosimilar of Remicade Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Biosimilar of Remicade Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Biosimilar of Remicade Market Share by Country (2016-2027)
Figure 60. Turkey Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Biosimilar of Remicade Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Roche Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 64. Amgen Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 65. AbbVie Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 66. Sanofi-Aventis Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 69. Novo Nordisk Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 70. Eli Lilly Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 71. Novartis Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 72. Merck Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 73. 3sbio Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 74. Changchun High Tech Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 75. CP Guojian Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 76. Biotech Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 77. Gelgen Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 78. Innovent Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 79. Dong Bao Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 80. Ganlee Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 81. United Laboratories Revenue Growth Rate in Biosimilar of Remicade Business (2016-2021)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
Keyplayers in Global Biosimilar of Remicade Market Size, Status and Forecast 2021-2027
RocheAmgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Request Sample
Request Discount
